Lower riskDrug recall · FDA · Published August 20, 2018
Hetero Labs Montelukast Tablets Recalled Due to Blue Specks
Hetero Labs Limited recalls 10mg Montelukast Sodium tablets with blue specks. This may affect prescription medication safety. Stop using and contact your pharmacist.
Discoloration: A complaint was received from a pharmacist for the presence of blue specks on tablets.
Take action
Contact the company
📍Recalling firmHetero Labs Limited Unit VUnit V (SEZ Unit I in APIIC SEZ), Surv. No. 439-441, 458, Polepally Vill. · Jadcherla Mandal, Mahaboob Nagar, India
“Hetero Labs Montelukast Tablets Recalled Due to Blue Specks.” GovInfoNow, updated October 6, 2026. https://govinfonow.com/recall/39710-hetero-labs-montelukast-tablets-recalled-due-to-blue-specks. Based on FDA recall #D-1213-2018 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1213-2018%22&limit=1).
The FDA announced on August 20, 2018, that Hetero Labs Limited Unit V is recalling Montelukast Sodium Tablets due to blue specks found on the tablets. Owners should stop using the product and contact the company for a refund. The recall affects 98,016 bottles distributed nationwide.
How to tell if you have it
Brand: Hetero Labs Limited
Product: Montelukast Sodium Tablets, 10 mg*, 30-count bottles, Rx Only
Manufacturer: Hetero, Hetero Labs Limited, Unit V, Polepally, Jadcherla, Mahaboob Nagar - 509 301, India
The hazard is discoloration, specifically blue specks on the tablets. The FDA stated that a complaint was received from a pharmacist regarding this issue.
Context
GovInfoNow's records show Hetero Labs Limited (Unit V) has had six other recalls since December 22, 2017. Other recent recalls of similar products include Hetero Labs Pantoprazole Tablets Recall (March 26, 2026), Hetero Labs Losartan Tablets Recall (August 6, 2020), and Hetero Labs Montelukast Tablets Recall (August 15, 2018). Other recent recalls of similar products include Sun Pharmaceutical Carbamazepine Tablets Recall (August 3, 2026), Golden State Medical Supply recalls Carbamazepine 200mg tablets (August 7, 2026), and Guardian Drug Goodsense Ultra Strength Antacid Tablets Recall (May 28, 2026).
How to tell if you have this one
Check for 10 mg Montelukast Sodium tablets with blue specks. The product was sold in India by Hetero Labs Limited, Unit V, with NDC 31722-726-30.
Brand
Hetero Labs Limited
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check for Blue Specks
Look for blue specks on the tablets. If present, stop using the product.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 3.2 years after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-1213-2018 (August 20, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1213-2018 to see it in context.
Plain-language summary written by qwen3:4b on October 6, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.